TY  - CHAP
M1  - Book, Section
TI  - Contraception
A1  - Shrader, Sarah P.
A1  - Ragucci, Kelly R.
A2  - DiPiro, Joseph T.
A2  - Talbert, Robert L.
A2  - Yee, Gary C.
A2  - Matzke, Gary R.
A2  - Wells, Barbara G.
A2  - Posey, L. Michael
Y1  - 2017
N1  - 
T2  - Pharmacotherapy: A Pathophysiologic Approach, 10e
AB  - Content  UpdateNovember  26,  2019New  Combined  Hormonal,  Intravaginal  Ring  for  Long-acting  Reversible  Contraception  (LARC):  In  2018,  the  U.S.  Food  and  Drug  Administration  (FDA)  approved  segesterone  acetate  and  ethinyl  estradiol  (Annovera)  for  pregnancy  prevention  in  females  of  reproductive  age.  The  combination  product  is  a  contraceptive  vaginal  system  that  can  be  self-administered  (21  days)  and  removed  (7  days)  each  month  for  up  to  one  year.  This  system  has  precautions,  contraindications,  and  side  effects  similar  to  other  combined  hormonal  contraceptives.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/20
UR  - accesspharmacy.mhmedical.com/content.aspx?aid=1168003432
ER  -